Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...

On 20 December 2021, the EU authorised the first protein-based vaccine (produced by Novavax) for use in the EU, following a positive recommendation of the European Medicines Agency. The Novavax ...

Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.

Effectiveness of 2024-25 COVID-19 vaccination against a COVID-19–associated ED/UC visit was 33% (95% confidence interval [CI] ...

Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the ... biotech to buy 60 million doses of the vaccine in August if trials work out. It’s one of several agreements ...

Although Novavax secured the FDA’s authorization for an updated version of its protein-based COVID-19 vaccine toward the end of August, it was delayed compared to the approvals/authorizations ...

Novavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnership Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...

Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a vaccine maker. The COVID-19 vaccine company, based in Maryland ...

Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...